LINCS Pilot Phase Joint Project: Sensitivity measures of six breast cancer cell lines to a library of small molecule kinase inhibitors (single drug treatments). Dataset 11 of 15: Mean cell count and mean normalized growth rate inhibition values across biological replicate 1. - Dataset (ID:20248)
Download: Excel (XLSX), Comma-separated (CSV)
Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | LJP Library Plate | Timepoint | Timepoint Unit | Mean Total Cell Count Before Treatment | Mean Total Cell Count After Treatment | Mean Total Control Cell Count | Mean Relative Cell Count | Mean Normalized Growth Rate Inhibition Value |
---|---|---|---|---|---|---|---|---|---|---|---|
MCF7 | Dovitinib | 0.12 | uM | LJP5 | 72 | hr | 1235 | 3441 | 4267 | 0.8060 | 0.7715 |
MCF7 | Dovitinib | 0.37 | uM | LJP5 | 72 | hr | 1235 | 3010 | 4267 | 0.7052 | 0.6448 |
MCF7 | Dovitinib | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2849 | 4267 | 0.6681 | 0.5960 |
MCF7 | Dovitinib | 3.33 | uM | LJP5 | 72 | hr | 1235 | 2215 | 4267 | 0.5192 | 0.3861 |
MCF7 | Dovitinib | 10 | uM | LJP5 | 72 | hr | 1235 | 2197 | 4267 | 0.5152 | 0.3802 |
MCF7 | GSK 690693 | 0.04 | uM | LJP5 | 72 | hr | 1235 | 2655 | 4267 | 0.6212 | 0.5305 |
MCF7 | GSK 690693 | 0.12 | uM | LJP5 | 72 | hr | 1235 | 2213 | 4267 | 0.5185 | 0.3840 |
MCF7 | GSK 690693 | 0.37 | uM | LJP5 | 72 | hr | 1235 | 2168 | 4267 | 0.5080 | 0.3685 |
MCF7 | GSK 690693 | 1.11 | uM | LJP5 | 72 | hr | 1235 | 2108 | 4267 | 0.4937 | 0.3469 |
MCF7 | GSK 690693 | 3.33 | uM | LJP5 | 72 | hr | 1235 | 2231 | 4267 | 0.5228 | 0.3912 |
MCF7 | GSK 690693 | 10 | uM | LJP5 | 72 | hr | 1235 | 2142 | 4267 | 0.5018 | 0.3581 |
MCF7 | SNS-032 | 0.04 | uM | LJP6 | 72 | hr | 1235 | 726 | 4056 | 0.1789 | -0.2671 |
MCF7 | SNS-032 | 0.12 | uM | LJP6 | 72 | hr | 1235 | 632 | 4056 | 0.1555 | -0.3278 |
MCF7 | SNS-032 | 0.37 | uM | LJP6 | 72 | hr | 1235 | 574 | 4056 | 0.1415 | -0.3617 |
MCF7 | SNS-032 | 1.11 | uM | LJP6 | 72 | hr | 1235 | 565 | 4056 | 0.1396 | -0.3669 |
MCF7 | SNS-032 | 3.33 | uM | LJP6 | 72 | hr | 1235 | 579 | 4056 | 0.1425 | -0.3583 |
MCF7 | SNS-032 | 10 | uM | LJP6 | 72 | hr | 1235 | 598 | 4056 | 0.1476 | -0.3446 |
MCF7 | Afatinib | 0.04 | uM | LJP6 | 72 | hr | 1235 | 2830 | 4056 | 0.6983 | 0.6221 |
MCF7 | Afatinib | 0.12 | uM | LJP6 | 72 | hr | 1235 | 2890 | 4056 | 0.7125 | 0.6409 |
MCF7 | Afatinib | 0.37 | uM | LJP6 | 72 | hr | 1235 | 3301 | 4056 | 0.8145 | 0.7745 |
MCF7 | Afatinib | 1.11 | uM | LJP6 | 72 | hr | 1235 | 3186 | 4056 | 0.7852 | 0.7355 |
MCF7 | Afatinib | 3.33 | uM | LJP6 | 72 | hr | 1235 | 2283 | 4056 | 0.5630 | 0.4305 |
MCF7 | Afatinib | 10 | uM | LJP6 | 72 | hr | 1235 | 664 | 4056 | 0.1637 | -0.3041 |
MCF7 | GSK1904529A | 0.04 | uM | LJP6 | 72 | hr | 1235 | 1953 | 4056 | 0.4815 | 0.3061 |
MCF7 | GSK1904529A | 0.12 | uM | LJP6 | 72 | hr | 1235 | 1785 | 4056 | 0.4400 | 0.2390 |